Charcot-Marie-Tooth disease type 2A2
MONDO:0012231Autosomal dominant Charcot-Marie-Tooth disease type 2A2 (CMT2A2) is a subtype of Autosomal dominant Charcot-Marie-Tooth disease type 2 characterized by the childhood onset of distal weakness and areflexia (with earlier and more severe involvement of the lower extremities), reduced sensory modalities (primarily pain and temperature sensation), foot deformities, postural tremor, scoliosis and contractures. Optic atrophy, vocal cord palsy with dysphonia, sensorineural hearing loss, spinal cord abnormalities and hydrocephalus have also been reported.
Also known as: CMT2A2, Charcot-Marie-Tooth disease type 2 caused by mutation in MFN2, Charcot-Marie-Tooth disease type 2A2A, Charcot-Marie-Tooth disease, axonal, type 2A2A, HMSN IIA2, HMSN2A2, MFN2 Charcot-Marie-Tooth disease type 2, hereditary motor and sensory neuropathy IIA2
10 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Laser test could objectively measure nerve pain for first time
Diagnosis CompletedThis study tested whether a diode laser can act as a biomarker to measure neuropathic pain in people with peripheral neuropathy. Researchers compared pain responses to a lidocaine patch versus a placebo patch in 75 participants. The goal was to see if the laser test could disting…
Phase: NA • Sponsor: University of Utah • Aim: Diagnosis
Last updated Jun 27, 2026 12:09 UTC
-
Huntington disease survey aims to make clinical trials more Participant-Friendly
Knowledge-focused CompletedThis completed survey study asked 131 people with or at risk for Huntington disease about their feelings, attitudes, and beliefs toward clinical research. The goal is to help researchers design better studies that are more aware of participants' needs. No treatment or drug was te…
Sponsor: Huntington Study Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC